0000000000823319

AUTHOR

Pavone Carlo

showing 2 related works from this author

Il Trasferimento Energetico Capacitivo Resistivo (TECAR) nella terapia dell’Induratio Penis Plastica: studio pilota di fase uno sulla tollerabilità, …

2013

Our phase-one prospective study wants to evaluate the safety and tolerability of TECAR therapy in the treatment of Peyronie’s disease. From June 2011 to September 2012 we enrolled 70 patients. Each patient had been previously subjected to andrological examination, to a questionnaire for the evaluation of IPP and ED, and the SF-36 (V1) for the evaluation of the general state of health. The evaluation of pain was made using the VAS scale of pain. Every patient was subjected to TECAR treatment of the fibrotic plaque (both in resistive mode and in capacitive mode) for a total of three sessions carried out on consecutive days. We recorded a good compliance by patients; none of them reported side…

Settore MED/34 - Medicina Fisica E RiabilitativaErectile dysfunction Peyronie’s disease TECARSettore MED/24 - Urologia
researchProduct

Does P-glycoprotein-170 expression predict for chemoresistance in transitional cell carcinoma of the bladder?

2003

Introduction: The glycoprotein P-170, causing drug efflux from the cells, may represent at least one cause of resistance to most drugs used in intravesical chemotherapy of superficial bladder cancer. Materials and Methods: GP-170 was retrospectively assessed in 60 patients affected by superficial transitional cell tumours of the bladder. It was assessed by immunohistochemistry in a semiquantitative way by the intensity of staining and by the percentage of positive cells. Correlation of GP-170 expression with G-grade, T-category, multiplicity, recurrence rate and treatment was investigated. In 44 patients recurrence was analysed in relation to GP-170 basal expression and to its variations. T…

MaleCarcinoma Transitional CellCancer ResearchATP Binding Cassette Transporter Subfamily BBladder carcinomaImmunohistochemistryIntravesical chemotherapySettore MED/24 - UrologiaAdministration IntravesicalUrinary Bladder NeoplasmsOncologyDrug Resistance NeoplasmPredictive Value of TestsGP-170HumansFemaleMDR-1ChemoresistanceGlycoproteinsNeoplasm StagingRetrospective Studies
researchProduct